about
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesIneffective erythropoiesis in β -thalassemiaIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesCurcumin Attenuates Iron Accumulation and Oxidative Stress in the Liver and Spleen of Chronic Iron-Overloaded Rats.New developments in therapeutic chelating agents as antidotes for metal poisoning.Diabetes and Glucose Metabolism in Thalassemia Major: An Update.Iron chelators: correlation between effects on Plasmodium spp. and immune functions.Effects of zinc-desferrioxamine on Plasmodium falciparum in culture.The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites.Inhibitory effects of deferoxamine on UVB-induced AP-1 transactivation.Risks of parenteral deferoxamine for acute iron poisoning.Iron-induced ascorbate oxidation in plasma as monitored by ascorbate free radical formation. No spin-trapping evidence for the hydroxyl radical in iron-overloaded plasma.Dietary supplementation with (R)-alpha-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex.Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia.Intranasal delivery of deferoxamine reduces spatial memory loss in APP/PS1 mice.
P2860
Q24289511-0CC03DAB-DFDB-498D-8576-0250FE53D132Q26830255-F4880BBD-8BB7-42EC-830E-B54D664B3CFFQ28388335-DCD30B5E-594B-4B65-972A-5F0C433FFA85Q35730325-F7B27C72-7638-4B6C-85B2-64776D6AD1E5Q37731908-E8DFA28C-78DC-4B9C-8277-BC79E8F1ED91Q38677212-1392BB11-BB59-49A6-8152-F893C5EF9489Q39026858-62EDE92E-38B5-433A-B8CC-3A2CB458D961Q39780309-C9026F46-7A09-406D-B552-41FC4DEDF621Q40512718-2EE9A414-C37E-45AC-BE4D-3019F557A4B8Q40919552-38E4DBE4-42CE-46F9-972A-D7EF8AE00015Q41107649-25271D48-DD14-47E9-AB0A-3D9C5DDE053EQ41828536-F1A61012-4B58-419F-9699-1E01D8D86657Q46436676-527815C4-5556-49B2-8093-B20F0D8743B6Q46581528-1C187943-538D-424B-81EE-0DD1843964F4Q48489668-881D7ACF-12A3-40A8-B619-9CE67B9EC310
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Iron-chelating therapy.
@en
Iron-chelating therapy.
@nl
type
label
Iron-chelating therapy.
@en
Iron-chelating therapy.
@nl
prefLabel
Iron-chelating therapy.
@en
Iron-chelating therapy.
@nl
P2860
P1476
Iron-chelating therapy.
@en
P2093
Weatherall DJ
P2860
P304
P356
10.3109/10408368809105894
P577
1988-01-01T00:00:00Z